HB0045 Injection

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB0045 Injection, covering 2023-10-23 to 2023-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HB0045 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]